These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7171745)

  • 1. Lipolytic and adenyl-cyclase-stimulating activity of glucagon 1-6: comparison with glucagon derivatives chemically modified in the 7-29 sequence.
    Jean-Baptiste E; Rizack MA; Epand RM
    Biosci Rep; 1982 Oct; 2(10):819-24. PubMed ID: 7171745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipolytic and adenyl-cyclase-stimulating activity of N alpha-trinitrophenyl glucagon: comparison with other glucagon derivatives modified at the amino terminus.
    Jean-Baptiste E; Rizack MA; Epand RM
    Biosci Rep; 1982 Mar; 2(3):163-7. PubMed ID: 7066487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of nonspecific hydrophobic interactions in the biological activity of N epsilon-acyl derivatives of glucagon. Studies of conformation, receptor binding, and adenylate cyclase activation.
    Carrey EA; Epand RM
    J Biol Chem; 1982 Sep; 257(18):10624-30. PubMed ID: 6286664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon carboxyl-terminal derivatives: preparation, purification, and characterization.
    England RD; Jones BN; Flanders KC; Coolican SA; Rothgeb TM; Gurd RS
    Biochemistry; 1982 Mar; 21(5):940-50. PubMed ID: 7074063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of age-related loss of glucagon-promoted lipolysis by food restriction.
    Voss KH; Masoro EJ; Anderson W
    Mech Ageing Dev; 1982 Feb; 18(2):135-49. PubMed ID: 6278234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for glucagon receptor binding and activation of adenylate cyclase in liver. Study of chemically modified forms of the hormone, including N alpha-trinitrophenyl glucagon, an antagonist.
    Epand RM; Rosselin G; Hoa DH; Cote TE; Laburthe M
    J Biol Chem; 1981 Feb; 256(3):1128-32. PubMed ID: 6256384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of starvation, refeeding, and fat feeding on adipocyte ghost adenyl cyclase activity.
    Gorman RR; Tepperman HM; Tepperman J
    J Lipid Res; 1972 Mar; 13(2):276-80. PubMed ID: 4335799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function relationships in glucagon. Re-evaluation of glucagon-(1-21).
    Frandsen EK; Thim L; Moody AJ; Markussen J
    J Biol Chem; 1985 Jun; 260(12):7581-4. PubMed ID: 2987259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in adipocyte response to lipolytic hormones during cold acclimation.
    Rochon L; Bukowiecki LJ
    Am J Physiol; 1990 May; 258(5 Pt 1):C835-40. PubMed ID: 2159229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semisynthetic glucagon derivatives for structure-function studies.
    Hruby VJ; Wright DE; Lin MC; Rodbell M
    Metabolism; 1976 Nov; 25(11 Suppl 1):1323-5. PubMed ID: 185491
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparation and properties of glucagon analogs prepared by semi-synthesis from CNBr-glucagon.
    Wright DE; Hruby VJ; Rodbell M
    Biochim Biophys Acta; 1980 Aug; 631(1):49-58. PubMed ID: 6249392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forskolin as a novel lipolytic agent.
    Ho R; Shi QH
    Biochem Biophys Res Commun; 1982 Jul; 107(1):157-64. PubMed ID: 6289816
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucocorticoid regulation of ACTH sensitivity of adenyl cyclase in rat fat cell membranes.
    Braun T; Hechter O
    Proc Natl Acad Sci U S A; 1970 Jul; 66(3):995-1001. PubMed ID: 4316684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of specific trinitrophenylation of the lysine epsilon amino group of glucagon on receptor binding and adenylate cyclase activation.
    Liepnieks JJ; Epand RM
    Arch Biochem Biophys; 1983 Aug; 225(1):102-9. PubMed ID: 6311099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenyl cyclase and hormone action. I. Effects of adrenocorticotropic hormone, glucagon, and epinephrine on the plasma membrane of rat fat cells.
    Bär HP; Hechter O
    Proc Natl Acad Sci U S A; 1969 Jun; 63(2):350-6. PubMed ID: 4308273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone receptors. I. Activation of rat liver plasma membrane adenylyl cyclase and fat cell lipolysis by agarose-glucagon.
    Johnson CB; Blecher M; Giorgio NA
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1035-41. PubMed ID: 5012158
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucagon: structure-function relationships investigated by sequence deletions.
    Frandsen EK; Grønvald FC; Heding LG; Johansen NL; Lundt BF; Moody AJ; Markussen J; Vølund A
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):665-77. PubMed ID: 6268519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sensitivity of adipocyte adenylate cyclase to glucagon in the fasted state.
    Chohan P; Saggerson D
    FEBS Lett; 1982 Sep; 146(2):357-60. PubMed ID: 7140982
    [No Abstract]   [Full Text] [Related]  

  • 19. A reassessment of structure-function relationships in glucagon. Glucagon1-21 is a full agonist.
    Wright DE; Hruby VJ; Rodbell M
    J Biol Chem; 1978 Sep; 253(18):6338-40. PubMed ID: 210180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic peptide antagonists of glucagon.
    Unson CG; Andreu D; Gurzenda EM; Merrifield RB
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4083-7. PubMed ID: 3035568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.